adamantane has been researched along with Lassitude in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderton, K; Bentz, TA; Brisendine, A; Britten, CD; Chin, SH; Cusack, SL; Garrett-Mayer, E; Maines, LW; Ogretmen, B; Shirai, K; Smith, CD; Thomas, MB; Zhuang, Y | 1 |
Glushchenko, VA; Karitsky, AP; Kvashnin, AV; Rozengard, SA; Ryazankina, AA | 1 |
2 trial(s) available for adamantane and Lassitude
Article | Year |
---|---|
A Phase I Study of ABC294640, a First-in-Class Sphingosine Kinase-2 Inhibitor, in Patients with Advanced Solid Tumors.
Topics: Adamantane; Adult; Aged; Dose-Response Relationship, Drug; Fatigue; Female; Humans; Male; Middle Aged; Nausea; Neoplasms; Phosphotransferases (Alcohol Group Acceptor); Pyridines; Treatment Outcome; Vomiting; Young Adult | 2017 |
[Optimization of pharmacological therapy for weakness syndrome in incurable patients].
Topics: Acetamides; Adamantane; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Antiemetics; Antineoplastic Agents; Dexamethasone; Dopamine; Drug Therapy, Combination; Fatigue; Female; Humans; Hypnotics and Sedatives; Ibuprofen; Male; Middle Aged; Muscle Weakness; Neoplasms; Ondansetron; Pentoxifylline; Radiation-Protective Agents; Serotonin; Serotonin Antagonists; Syndrome; Treatment Outcome | 2015 |